TC BioPharm TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products. | Suvoda Suvoda is a global clinical trial technology company focusing on oncology, central nervous system, and rare disease. | Akoya Biosciences Akoya Biosciences is a biotechnology company specializing in high-parameter tissue analysis. | FLAG Therapeutics FLAG Therapeutics is an early-stage oncology company focused on the development of therapies based on two investigational product platforms. | |
Founding Date | Founding Date 2013 | Founding Date 2013 | Founding Date 2015 | Founding Date 2013 |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Holytown, GB HQ Leiden, NL Edinburgh, GB London, GB | Locations Conshohocken, US HQ Tokyo, JP București, RO Barcelona, ES Portland, US | Locations Marlborough, US HQ Menlo Park, US | Locations Raleigh, US HQ |
Employees | Employees 41 | Employees 965 | Employees 33011% decrease | Employees 2 |
Valuation ($) | Valuation ($) 926.7 k | Valuation ($) N/A | Valuation ($) 143.5 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $96.6m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $40.3m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $56.3m (FY, 2023) | Gross profit N/A |
Net income | Net income (£5.9m) (FY, 2023) | Net income N/A | Net income ($63.3m) (FY, 2023) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 40m (about 5 years ago) | Latest funding round N/A | Latest funding round $ 1.3m (about 6 years ago) |
Total funding raised | Total funding raised $ 33.2m | Total funding raised $ 40m | Total funding raised $ 83.5m | Total funding raised $ 1.8m |